| 1 |
35054486 | Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. | 2022 Jan 10 |
1 |
| 2 |
32021441 | ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway. | 2020 |
1 |
| 3 |
33081566 | Tumor-associated macrophages promote human hepatoma Huh-7 cell migration and invasion through the Gli2/IGF-II/ERK1/2 axis by secreting TGF-β1. | 2020 Nov 1 |
2 |
| 4 |
31592660 | An AND-Gated Drug and Photoactivatable Cre-loxP System for Spatiotemporal Control in Cell-Based Therapeutics. | 2019 Oct 18 |
1 |
| 5 |
29589904 | Engineering a Dual Small Molecule Gated ZAP70 Switch in T Cells. | 2018 Apr 20 |
1 |
| 6 |
29945962 | Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer. | 2018 Sep 1 |
1 |
| 7 |
28026072 | Activation of KLF1 Enhances the Differentiation and Maturation of Red Blood Cells from Human Pluripotent Stem Cells. | 2017 Apr |
1 |
| 8 |
28423577 | The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance. | 2017 Apr 4 |
1 |
| 9 |
28855706 | Chondrogenesis and osteogenesis are one continuous developmental and lineage defined biological process. | 2017 Aug 30 |
1 |
| 10 |
27378269 | Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer. | 2016 Jul 4 |
1 |
| 11 |
25727020 | Omega-3 free fatty acids inhibit tamoxifen-induced cell apoptosis. | 2015 Apr 3 |
3 |
| 12 |
25846733 | ObRb downregulation increases breast cancer cell sensitivity to tamoxifen. | 2015 Sep |
1 |
| 13 |
26096876 | Tamoxifen Inhibits TGF-β-Mediated Activation of Myofibroblasts by Blocking Non-Smad Signaling Through ERK1/2. | 2015 Dec |
2 |
| 14 |
26487496 | Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer. | 2015 Nov |
1 |
| 15 |
26909308 | A human beta cell line with drug inducible excision of immortalizing transgenes. | 2015 Dec |
1 |
| 16 |
24447434 | Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment. | 2014 Jan 21 |
1 |
| 17 |
24481325 | GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts. | 2014 Apr |
2 |
| 18 |
24658355 | Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity. | 2014 Feb 28 |
1 |
| 19 |
24874276 | GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells. | 2014 Sep |
2 |
| 20 |
25085753 | ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer. | 2014 Aug |
2 |
| 21 |
23338782 | Dose-dependent effect of tamoxifen in tamoxifen-resistant breast cancer cells via stimulation by the ERK1/2 and AKT signaling pathways. | 2013 Apr |
3 |
| 22 |
23843844 | Leptin as a potential target for estrogen receptor-positive breast cancer. | 2013 Jun |
1 |
| 23 |
22279179 | Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-active copper chelate. | 2012 Apr |
1 |
| 24 |
22427054 | Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells. | 2012 Jun |
2 |
| 25 |
23086641 | [Effect of Evn-50 on cell growth and apoptosis in tamoxifen-resistance human breast cancer cell line MCF-7/TAM-R]. | 2012 Sep |
4 |
| 26 |
21175263 | Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals. | 2011 Jun |
2 |
| 27 |
21256460 | A novel role for tamoxifen in the inhibition of human platelets. | 2011 Feb |
3 |
| 28 |
21720253 | Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer. | 2011 Nov |
1 |
| 29 |
20889557 | High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. | 2010 Nov |
1 |
| 30 |
19115248 | Effect of tamoxifen and retinoic acid on bradykinin induced proliferation in MCF-7 cells. | 2009 Feb 15 |
2 |
| 31 |
19544110 | Activated PKCalpha/ERK1/2 signaling inhibits tamoxifen-induced apoptosis in C6 cells. | 2009 Aug |
2 |
| 32 |
17363451 | Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen. | 2007 Jun |
4 |
| 33 |
16261397 | Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. | 2006 Mar |
1 |
| 34 |
16455819 | Activation function-1 domain of estrogen receptor regulates the agonistic and antagonistic actions of tamoxifen. | 2006 May |
7 |
| 35 |
16603346 | Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen. | 2006 May |
2 |
| 36 |
16740736 | Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance. | 2006 Jun 1 |
5 |
| 37 |
15502196 | Targeted somatic mutagenesis in the mouse epidermis. | 2005 |
2 |
| 38 |
15806151 | ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. | 2005 Jun 23 |
1 |
| 39 |
15173068 | Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells. | 2004 Jun 1 |
1 |
| 40 |
14531500 | Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells. | 2003 Sep |
1 |
| 41 |
11773440 | Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. | 2002 Jan |
1 |
| 42 |
12060612 | Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. | 2002 Jun |
1 |
| 43 |
9372245 | CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells. | 1997 Nov |
1 |